New diabetes clinical trial: SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

Published on: February 27, 2020 at 10:30PM
Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: Semaglutide
Sponsor:   Novo Nordisk A/S
Not yet recruiting
https://ift.tt/3a7zU6E